Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Before self-diagnosing yourself, see a doctor to eliminate the possibility of other disorders
Yes, Melanotan-1 (afamelanotide) received FDA approval in 2019 under the trade name SCENESSE for erythropoietic protoporphyria (EPP), a rare genetic disorder causing extreme photosensitivity and severe pain upon sun exposure
Real-world feedbacklike the results from our community surveywill play a vital role in helping people make informed choices
These results are consistent with clinical trial outcomes, demonstrating that clinically relevant endpoints can be addressed at the preclinical stage
US$ 25.05
US$ 22.35
US$ 22.84
US$ 23.35
US$ 22.84
US$ 29.30
-1775582746855.png&w=3840&q=75)
US$ 27.29
US$ 20.03
